clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Popular Weight Loss Drugs Unlikely to Directly Affect Behavior
Coronavirus
New AI-Based Blood Test Detects Long COVID in Children with 93%…
News & Features
Dana-Farber Scientists Develop PET Probe to Image Inflammation with High Sensitivity
News & Features
New Combination Immunotherapy Targets Melanoma and Breast Cancer with Promising Results
News & Features
Moderate Calorie Restriction Plus SGLT-2 Achieves Higher Diabetes Remission Rate
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Inside Precision Medicine
Personalis, Merck KGaA Launch Cancer Biomarker Collaboration
Merck KGaA
News & Features
Personalis, Merck KGaA Launch Cancer Biomarker Collaboration
November 19, 2019
0
Informatics
Merck KGaA, Palantir Form Joint Venture to Develop Cancer Data Platform
November 20, 2018
0
Molecular Dx
Merck Partnering with ArcherDX on Cancer Companion Diagnostics
October 3, 2018
0
News & Features
Definiens, Merck KGaA Launch Digital Pathology Biomarker Collaboration
September 10, 2018
0
Molecular Dx
HTG Expands Collaboration with Merck KGaA Beyond CDx
December 27, 2017
0
News & Features
Human Longevity Joins Merck in Study to Identify Melanoma Biomarkers
June 15, 2017
0
News & Features
R-Biopharm, Merck KGaA Launch Companion Diagnostics Collaboration
March 22, 2016
0
News & Features
Illumina, Merck Serono to Partner on NGS-Based Cancer Diagnostics
March 10, 2015
0
Related Content
Popular Weight Loss Drugs Unlikely to Directly Affect Behavior
Dana-Farber Scientists Develop PET Probe to Image Inflammation with High Sensitivity
New Combination Immunotherapy Targets Melanoma and Breast Cancer with Promising Results
Polygenic Risk Score Improves COPD Diagnosis
Inside Precision Medicine
![Merck KGaA and software company Palantir Technologies are forming a joint venture to develop a collaborative technology platform to advance cancer research. [© Robert Mizerek/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/2015.jpeg "Merck KGaA, Palantir Form Joint Venture to Develop Cancer Data Platform")
